Salt sensitivity and cardiovascular risk

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 2, 1999, Pages 199-203

  Bataineh, Ahnaf ^a   Raij, Leopoldo ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY RISK; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; SODIUM METABOLISM;

EID: 0032967657     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199903000-00008     Document Type: Review

References (50)

1. Campese V. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994; 23:531-550.
2. Falkner B, Kushner H. Effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension 1990; 15:36-43.
3. Overlack A, Rupper M, Kolloch R, Kraft K, Stumpe KO. Age is a major determinant of the divergent blood pressure responses to varying sah intake in essential hypertension. Am J Hypertens 1995; 8:829-836.
4. Murakami K, Kojima S, Kimura G, Sanai T, Yoshida K, Imanishi M. The association between satt sensitivity of blood pressure and family history of hypertension. Clin Exp Pharmacol Physiol 1992; 20 (Suppl.):61-63.
5. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results of 24 hour urinary sodium and potassium excretion. BMJ 1998; 297:319-328.
6. Carvalho JJ, Baruzzi RG, Howard PF, Poultier N, Alpers MP, Franco LJ. Blood pressure in four remote population in the INTERSALT study. Hypertension 1989; 14:238-246.
7. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisone P. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1:1009-1016.
8. Widgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure. JAMA 1996; 275:1590-1597.
9. Luft FC. Salt and hypertension: where things stand. Nephrol Dial Transplant 1995; 10:1524-1525.
10. Cappuccio FP, Markandu ND, Carney C, Sagnella GA, MacGregor GA. Double-blind randomized trial of modest salt restriction in older people. Lancet 1997; 350:850-854. This is a double blind randomized study that examines the effect of modest salt restriction (from 10 to 5 g) on blood pressure in 47 untreated elderly people. A modest restriction in salt intake resulted in a fall in blood pressure from 163/90 to 156/87.
11. Sullivan JM. Salt sensitivity: definition, conception, methodology, and long-term issues. Hypertension 1991; 17 (Suppl. I):I-61-I-68.
12. Grim CE, Weinberger MH, Higgins JT, Kramer NJ. A rapid and efficient protocol for the diagnosis of secondary forms of hypertension. JAMA. 1977; 237:1331-1335.
13. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8 (Suppl. II):II-127-II-134.
14. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988; 78:951-956.
15. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H and the Intersalt Cooperative Research Group, Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996; 312:1249-1253.
16. Sohmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatza CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-1309.
17. de la Sierra A, Lluch MM, Pare JC, Coca A, Aguilera MT, Azqueta M. Increased left ventricular mass in salt-sensitive hypertensive patients. J Hum Hypertens 1996; 10:795-799.
18. Barba G, Cappuccio FP, Russo L, Stinga F, Lacone R, Strazzullo P. Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension 1996; 27:1160-1164
19. Nesovic M, Stojanovic M, Nesovic MM, Cirie J, Zarkovic M. Microalbuminuria is associated with salt sensitivity in hypertensive patients. J Hum Hypertens 1996, 10:573-576.
20. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 1997; 29:235-241. This study examines the relationship between LVH, salt sensitivity and aortic NOS activity in spontaneous hypertensive rats and Dahl salt-sensitive rats matched for blood pressure and age. Compared with SHRs, Dahl salt-sensitive rats failed to upregulate NOS in response to hypertension, and developed aortic hypertrophy and LVH.
21. Hayakawa H, Coffee K, Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 1997; 96:2407-2413.
22. Hayakawa H, Raij L. Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 1998; 31:266-270. This study investigates the relationship between salt sensitivity, renal NOS activity and glomerular and tubulointerstitial injury. Compared with SHRs, Dahl salt-sensitive rats have lower renal NOS activity, despite hypertension of similar severity and duration. They also had a ninefold increased incidence of glomerular injury and 20-fold more tubulointerstitial injury.
23. Raij L, Baytis C. Glomerular actions of nitric oxide [Editorial Review]. Kidney Int 1995; 48:20-32.
24. Galletti F, Strazullo P, Ferrara I, Annuzzi G, Rivellese AA, Gatto S. NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J Hypertens 1997, 15:1485-1491. A study of 99 patients with untreated hypertension. Compared with non-salt-sensitive hypertensive individuals, patients with satt sensitivity were also insulin-resistant.
25. Bigazzi R, Blanchi S, Baldari G, Campese VM Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996; 9:24-32.
26. Kannel WB, Stamper MJ, Castelli WP, Veter J. The prognostic significance of proteinuria: the Framingham Study. Am Heart J 1984; 108:1347-1352.
27. Zavaroni I, Bonoro E, Pasiliara M, Luchetti L, Bunannog G, Bonati PA. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320:702-706.
28. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-sensitive hypertension in human. Am J Hypertens 1997; 10:1083-1090 This study examines the relationship between endothelium-dependent vasodilation and salt sensitivity in patients with essential hypertension. Compared with salt-resistant patients, salt-sensitive subjects showed a reduced endothelium-dependent vasodilation in response to acetylcholine. This suggests that endothelial function is impaired in salt-sensitive hypertensive individuals.
29. Avolio AP, Deng FQ, Li WQ, Qiang LW, Fei LY, Dong HZ Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71:202-210.
30. Lee MA, Bohm M, Paul M, Gawler D. Tissue renin angiotensin systems. Their role in cardiovascular disease. Circulation 1993; 87 (Suppl. IV):7-13.
31. Ketteler M, Noble NA, Border WA. Transforming growth factor-β and angiotensin II: the missing link from glomerular hyperfiltration to glomerular sclerosis? Ann Rev Physiol 1995; 57:279-295.
32. Gnendling KK, Minien CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 1994; 74:1141-1148.
33. Hiroyuki H, Tetsuya O, Mitsuaki W, Mari I, Takafumi I, Tetsuji S, et al. Angiotensin 1-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996; 27:569-572.
34. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Böhm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 1998; 31:1272-1277. An interesting study shows that sodium chloride may directly induce angiotensin type 1 receptor upregulation in vitro as well as vivo. This suggests a potential mechanism participating in salt-induced hypertension.
35. Campell OH, Haberer JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78:31-39.
36. Fenoy FJ, Ferrer P, Carbonell LF, Garcia SM. Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension 1995; 25:408-414.
37. Chen PY, Sanders PW L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88:1559-1567.
38. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation in hypertension. Am J Med 1972; 52:484-594.
39. Rettig R, Folberth C, Stauss H, Kopf D, Waldherr R, Unger T. Role of the kidney in primary hypertension. A renal transplantation study in rats. Am J Physiol 1990; 258:F606-F611.
40. Tripodi, G, Valtorta, F, Tonelli, L, Chiergatti E, Salardi S, Trusolino L. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97:2815-2822.
41. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M. Polymorphism of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353. This study suggests that alpha-adducin gene polymorphism is associated with salt sensitivity in hypertension.
42. Stamler J, Stamler R, Newton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153:5598-5615.
43. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from hypertension detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 (Suppl. 5):180-193.
44. Parving HH. Microalbuminuria in essential hypertension and diabetes. J Hypertens 1996; 14 (Suppl. 2):S89-S93.
45. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
46. Bigazzi R, Bianchi S, Baldari D, Campese VM, Sgherri G, Baldari G. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994; 23:195-199.
47. Coca A, de la Sierra A. Salt sensitivity and left ventricular hypertrophy. Adv Exp Med Biol 1997; 432:91-101.
48. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997, 350:1734-1737. In 62 salt-sensitive and 94 non-salt-sensitive patients, LVH and cardiovascular events occurred more frequently in the salt-sensitive group. Salt sensitivity was also found to be an independent cardiovascular risk factor.
49. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F. The deletion of polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 1996; 7:2250-2258.
50. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chanfellier G, Sert C, Dusselier L, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J Clin Invest 1997; 99:1585-1595.